h1

000782232 001__ 782232
000782232 005__ 20210223200411.0
000782232 0247_ $$2HSB$$aeva31735
000782232 0247_ $$2ISSN$$a0732-183X
000782232 0247_ $$2ISSN$$a1527-7755
000782232 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85077945273
000782232 0247_ $$2WOS$$aWOS:000508197300010
000782232 0247_ $$2doi$$a10.1200/JCO.19.01053
000782232 0247_ $$2pmid$$apmid:31794324
000782232 037__ $$aRWTH-2020-01746
000782232 041__ $$aEnglish
000782232 082__ $$a610
000782232 1001_ $$aLübbert, Michael$$b0$$eCorresponding author
000782232 245__ $$aValproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial$$honline, print
000782232 260__ $$aAlexandria, Va.$$bAmerican Society of Clinical Oncology$$c2020
000782232 3367_ $$00$$2EndNote$$aJournal Article
000782232 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
000782232 3367_ $$2BibTeX$$aARTICLE
000782232 3367_ $$2DRIVER$$aarticle
000782232 3367_ $$2DataCite$$aOutput Types/Journal article
000782232 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000782232 588__ $$aDataset connected to Web of Science, Web of Science, , CrossRef
000782232 591__ $$aGermany
000782232 7001_ $$aGrishina, Olga$$b1
000782232 7001_ $$aSchmoor, Claudia$$b2
000782232 7001_ $$aSchlenk, Richard F.$$b3
000782232 7001_ $$0P:(DE-82)021451$$aJost, Edgar$$b4$$urwth
000782232 7001_ $$0P:(DE-82)008071$$aCrysandt, Martina$$b5$$urwth
000782232 7001_ $$aHeuser, Michael$$b6
000782232 7001_ $$aThol, Felicitas$$b7
000782232 7001_ $$aSalih, Helmut R.$$b8
000782232 7001_ $$aSchittenhelm, Marcus M.$$b9
000782232 7001_ $$aGerming, Ulrich$$b10
000782232 7001_ $$aKuendgen, Andrea$$b11
000782232 7001_ $$aGötze, Katharina S.$$b12
000782232 7001_ $$aLindemann, Hans-Walter$$b13
000782232 7001_ $$0P:(DE-82)067393$$aMüller-Tidow, Carsten$$b14
000782232 7001_ $$aHeil, Gerhard$$b15
000782232 7001_ $$aScholl, Sebastian$$b16
000782232 7001_ $$aBug, Gesine$$b17
000782232 7001_ $$aSchwaenen, Carsten$$b18
000782232 7001_ $$aGiagounidis, Aristoteles$$b19
000782232 7001_ $$aNeubauer, Andreas$$b20
000782232 7001_ $$aKrauter, Jürgen$$b21
000782232 7001_ $$aBrugger, Wolfram$$b22
000782232 7001_ $$0P:(DE-82)158699$$ade Wit, Maike$$b23
000782232 7001_ $$aWäsch, Ralph$$b24
000782232 7001_ $$aBecker, Heiko$$b25
000782232 7001_ $$aMay, Annette M.$$b26
000782232 7001_ $$aDuyster, Justus$$b27
000782232 7001_ $$aDöhner, Konstanze$$b28
000782232 7001_ $$aGanser, Arnold$$b29
000782232 7001_ $$aHackanson, Björn$$b30
000782232 7001_ $$aDöhner, Hartmut$$b31
000782232 7001_ $$aDECIDER Study Team$$b32$$eCollaboration author
000782232 773__ $$0PERI:(DE-600)2005181-5$$a10.1200/JCO.19.01053$$n3$$p257-270$$tJournal of clinical oncology$$v38$$x1527-7755$$y2020
000782232 909CO $$ooai:publications.rwth-aachen.de:782232$$pVDB
000782232 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)021451$$aRWTH Aachen$$b4$$kRWTH
000782232 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)008071$$aRWTH Aachen$$b5$$kRWTH
000782232 9141_ $$y2020
000782232 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
000782232 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN ONCOL : 2017
000782232 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000782232 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000782232 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-04
000782232 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000782232 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-04
000782232 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000782232 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000782232 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000782232 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000782232 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000782232 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000782232 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-09-04$$wger
000782232 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000782232 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000782232 915__ $$0StatID:(DE-HGF)9925$$2StatID$$aIF >= 25$$bJ CLIN ONCOL : 2017
000782232 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
000782232 961__ $$c2020-02-04T13:53:38.356444$$x2020-02-04T13:53:38.356444$$z2020-02-04T13:53:38.356444
000782232 980__ $$aI:(DE-82)531040-2_20140620
000782232 980__ $$aUNRESTRICTED
000782232 980__ $$aVDB
000782232 980__ $$ajournal